1. Home
  2. LSF vs BDSX Comparison

LSF vs BDSX Comparison

Compare LSF & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laird Superfood Inc.

LSF

Laird Superfood Inc.

HOLD

Current Price

$2.40

Market Cap

23.8M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$17.88

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSF
BDSX
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Precision Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
122.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LSF
BDSX
Price
$2.40
$17.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$32.50
AVG Volume (30 Days)
41.8K
153.6K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
75.28
N/A
EPS
N/A
N/A
Revenue
$43,295,137.00
$88,499,000.00
Revenue This Year
$15.87
$23.35
Revenue Next Year
$14.98
$19.33
P/E Ratio
N/A
N/A
Revenue Growth
26.50
24.08
52 Week Low
$1.98
$0.25
52 Week High
$7.94
$20.21

Technical Indicators

Market Signals
Indicator
LSF
BDSX
Relative Strength Index (RSI) 33.76 62.47
Support Level $1.98 $6.33
Resistance Level $2.76 N/A
Average True Range (ATR) 0.19 1.84
MACD -0.04 0.20
Stochastic Oscillator 6.15 65.98

Price Performance

Historical Comparison
LSF
BDSX

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: